Immobilization-Related Hypercalcemia in a COVID-19 Patient With Prolonged Intensive Care Unit Stay.

Mesland, Jean-Baptiste;Collienne, Christine;Laterre, Pierre-François;Hantson, Philippe
(2022) American Journal of Physical Medicine and Rehabilitation — Vol. 101, n° 1, p. 61-63 (2022)

Files

2022_Mesland_Am_J_Phys_Med_Rehabil.pdf
  • Open Access
  • Adobe PDF
  • 133.99 KB
Download

Details

Authors
Abstract
Immobilization-related hypercalcemia is an uncommon finding in patients admitted to intensive care unit. We report a case of severe hypercalcemia in a COVID-19 patient admitted to intensive care unit for hypoxemic respiratory failure. He developed an acute kidney injury requiring continuous renal replacement therapy with regional citrate anticoagulation. Citrate chelates ionized calcium and stop the coagulation cascade locally, preventing filter clotting. Calcium is then given intravenously to a specific target (normocalcemia). It is only when calcium infusion has been stopped that bone resorption and hypercalcemia were unmasked.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Mesland, J.-B., Collienne, C., Laterre, P.-F., & Hantson, P. (2022). Immobilization-Related Hypercalcemia in a COVID-19 Patient With Prolonged Intensive Care Unit Stay. American Journal of Physical Medicine and Rehabilitation, 101(1), 61-63. https://doi.org/10.1097/PHM.0000000000001907 (Original work published 2022)